Today: 19 July 2026
National Grid share price slips as gilt yields climb — what to watch next for NG.L
29 January 2026
1 min read

National Grid share price slips as gilt yields climb — what to watch next for NG.L

LONDON, Jan 29, 2026, 08:58 GMT — Regular session.

  • Shares in National Grid dropped 0.7% in early London trading, following a fresh 52-week peak reached just yesterday.
  • Rising UK gilt yields are squeezing “bond proxy” utilities as rate speculation heats up ahead of the Bank of England.
  • Investors will also keep an eye on National Grid’s RIIO‑T3 regulatory briefing scheduled for Thursday.

National Grid shares dipped Thursday morning, retreating from the one-year peak reached in the last session. The pullback came amid rising UK bond yields, which pressured dividend-heavy utility stocks.

This shift is significant since regulated utilities often trade like bond substitutes. As government borrowing costs climb, their reliable cashflows lose appeal, and for companies that frequently raise debt, financing costs tick up at the edges.

By 0831 GMT, 10-year UK gilt yields hit 4.569%, their highest since Nov. 20, following the U.S. Federal Reserve’s decision to keep rates steady. Fed Chair Jerome Powell called the economic outlook “clearly improving.” Meanwhile, money markets expect the Bank of England to keep rates at 3.75% next week, with just about 33 basis points of cuts priced in for 2026 — a basis point equals one hundredth of a percentage point. London South East

National Grid slipped 0.65% to 1,222.5 pence, falling short of its 52-week peak of 1,231 pence reached on Wednesday. The previous session ended with the stock at 1,230.5 pence.

The FTSE 100 index gained roughly 0.6% during the session, pushing the defensive utility stock behind in the early trading.

Societe Generale, serving as stabilisation coordinator, announced that stabilisation managers might carry out price-support operations for an anticipated 500 million euro securities offering from National Grid Electricity Transmission plc. The post-sale “stabilisation” process aims to steady trading, with the notice specifying it will end by March 5 at the latest. Investegate

National Grid’s U.S. arm reported operational strains this week linked to storm damage, restoring power to over 8,800 Massachusetts customers after Winter Storm Fern. Chris Laird, COO for electric at National Grid New England, emphasized the challenge: “With sub-freezing temperatures the norm in recent weeks, it is critically important that we deliver for our customers.” National Grid

Bond yields remain the key driver. Should gilts continue to sell off, utilities could stay under pressure, even without any negative news from individual companies. A swift shift in rate expectations, though, would shift the mood fast.

Regulation continues to be a critical factor for National Grid, as a significant portion of its UK profits depend on returns determined by the regulator. Even minor changes in allowed returns or incentives can have a big impact across a five-year control period.

National Grid will hold a RIIO‑T3 final determination webinar at 10:30 a.m. on Thursday to outline the regulator’s decision and what it means for stakeholders.

In the UK, the company plans to reveal its response in early March 2026, following a review of Ofgem’s final determination covering the April 2026 to March 2031 period.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • U.S. Bio Stocks Climb on M&A Momentum, Korean Bio Shares Drop Back
    July 19, 2026, 5:29 PM EDT. U.S. bio stocks rise further, fueled by active mergers and acquisitions and gains in biotech ETFs, as Korean bio stocks see steep declines. The KOSDAQ 150 Biotech index slid 20.63% in the last month, while bio ETFs such as UNICORN K BioActive lost 19.56%. In the U.S., the Nasdaq Biotech Index is approaching a 52-week high, and U.S.-focused ETFs like KODEX US S&P Bio added 13.62%. The relationship between Korean and U.S. bio indices has shifted, with the correlation moving from positive (0.55) to negative (-0.63). Driving the divergence are robust U.S. biotech M&A deals and sales cycles, while Korean bio names lag as funds turn toward major semiconductor stocks and broader market performance remains weak.
Intuit stock price dips as AI fears circle TurboTax, but RBC sticks with $850 target
Previous Story

Intuit stock price dips as AI fears circle TurboTax, but RBC sticks with $850 target

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work
Next Story

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work

Go toTop